Comprehensive assessment of knee joint synovitis at 7 T MRI using contrast-enhanced and non-enhanced sequences

[1] Ladd ME(2018)Pros and cons of ultra-high-field MRI/MRS for human application Prog Nucl Magn Reson Spectrosc 109 1-50

[2] Bachert P(2014)Progress in imaging in rheumatology Nat Rev Rheumatol 10 628-634

[3] Meyerspeer M(2014)Optimal use of MRI in clinical trials, clinical care and clinical registries of patients with rheumatoid arthritis Clin Exp Rheumatol 32 S-17-S-22

[4] Moser E(2017)Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis? Ann Rheum Dis 76 e45-2131

[5] Nagel AM(2003)New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier Arthritis Rheum 48 2128-1119

[6] Norris DG(2016)Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis Ann Rheum Dis 75 1114-1386

[7] Filippucci E(2003)OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system J Rheumatol 30 1385-271

[8] Di Geso L(2017)Comparison between semiquantitative and quantitative methods for the assessment of knee synovitis in osteoarthritis using non-enhanced and gadolinium-enhanced MRI Osteoarthr Cartil 25 267-1274

[9] Grassi W(2010)Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI Osteoarthr Cartil 18 1269-112

[10] Ostergaard M(2015)Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results Eur Radiol 25 106-433

[1] Ladd ME(2018)Pros and cons of ultra-high-field MRI/MRS for human application Prog Nucl Magn Reson Spectrosc 109 1-50

[2] Bachert P(2014)Progress in imaging in rheumatology Nat Rev Rheumatol 10 628-634

[3] Meyerspeer M(2014)Optimal use of MRI in clinical trials, clinical care and clinical registries of patients with rheumatoid arthritis Clin Exp Rheumatol 32 S-17-S-22

[4] Moser E(2017)Is MRI a predictive biomarker for clinical response to biologics in rheumatoid arthritis? Ann Rheum Dis 76 e45-2131

[5] Nagel AM(2003)New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier Arthritis Rheum 48 2128-1119

[6] Norris DG(2016)Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis Ann Rheum Dis 75 1114-1386

[7] Filippucci E(2003)OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system J Rheumatol 30 1385-271

[8] Di Geso L(2017)Comparison between semiquantitative and quantitative methods for the assessment of knee synovitis in osteoarthritis using non-enhanced and gadolinium-enhanced MRI Osteoarthr Cartil 25 267-1274

[9] Grassi W(2010)Anatomical distribution of synovitis in knee osteoarthritis and its association with joint effusion assessed on non-enhanced and contrast-enhanced MRI Osteoarthr Cartil 18 1269-112

[10] Ostergaard M(2015)Brain tumours at 7T MRI compared to 3T--contrast effect after half and full standard contrast agent dose: initial results Eur Radiol 25 106-433